Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis
作者： Josée Golay , Luisella Zaffaroni , Thomas Vaccari , Manuela Lazzari , Gian-Maria Borleri
DOI: 10.1182/BLOOD.V95.12.3900
关键词: Antibody 、 Cancer research 、 Lymphoma 、 Cytotoxicity 、 Rituximab 、 Antibody-dependent cell-mediated cytotoxicity 、 Antigen 、 Immunology 、 Monoclonal 、 Biology 、 CD59
摘要: … in fresh cases of FL: Blocking CD55 and/or CD59 function with … Furthermore, we suggest that the relative levels of CD55 and … not inhibit proliferation or induce significant apoptosis in any …
ashpublications.org
elsevier.com
bloodjournal.org参考文章(41)
V. Diehl, A. Lister, J.A. Radford, D. Ma, P. Johnson, A. Engert, F. Reyes, C. Haioun, H. Tilly, R. Capdeville, B. Coiffier, N. Ketterer, M. Feuring Buske, Rituximab (Anti-CD20 Monoclonal Antibody) for the Treatment of Patients With Relapsing or Refractory Aggressive Lymphoma: A Multicenter Phase II Study Blood. ,vol. 92, pp. 1927- 1932 ,(1998) , 10.1182/BLOOD.V92.6.1927
D. R. Anderson, A. Grillo-López, C. Varns, K. S. Chambers, N. Hanna, TARGETED ANTI-CANCER THERAPY USING RITUXIMAB, A CHIMAERIC ANTI-CD20 ANTIBODY (IDEC-C2B8) IN THE TREATMENT OF NON-HODGKIN'S B-CELL LYMPHOMA Biochemical Society Transactions. ,vol. 25, pp. 705- 708 ,(1997) , 10.1042/BST0250705
ME Reff, K Carner, KS Chambers, PC Chinn, JE Leonard, R Raab, RA Newman, N Hanna, DR Anderson, Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20 Blood. ,vol. 83, pp. 435- 445 ,(1994) , 10.1182/BLOOD.V83.2.435.435
Daming Shan, Jeffrey A. Ledbetter, Oliver W. Press, Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies Blood. ,vol. 91, pp. 1644- 1652 ,(1998) , 10.1182/BLOOD.V91.5.1644
Michael W. White, Edward A. Clark, Geraldine L. Shu, David R. Morris, Fiona Mcconnell, Activation of dense human tonsilar B cells. Induction of c-myc gene expression via two distinct signal transduction pathways. Journal of Immunology. ,vol. 146, pp. 846- 853 ,(1991)
Gorter A, Blok Vt, Daha Mr, Morgan Bp, Tijsma O, Harris Cl, Fleuren Gj, A Bispecific Monoclonal Antibody Directed Against Both the Membrane-Bound Complement Regulator CD55 and the Renal Tumor-Associated Antigen G250 Enhances C3 Deposition and Tumor Cell Lysis by Complement Journal of Immunology. ,vol. 160, pp. 3437- 3443 ,(1998)
M. Kathryn Uszewski, Timothy C. Farries, Douglas M. Lublin, Isabelle A. Rooney, John P. Atkinson, Control of the complement system. Advances in Immunology. ,vol. 61, pp. 201- 283 ,(1996) , 10.1016/S0065-2776(08)60868-8
C H Uittenbogaart, K A Licciardi, E A Clark, N G Ahn, J Wietzerbin, M A Valentine, E M Genot, K E Meier, Phosphorylation of CD20 in cells from a hairy cell leukemia cell line. Evidence for involvement of calcium/calmodulin-dependent protein kinase II. Journal of Immunology. ,vol. 151, pp. 71- 82 ,(1993)
E A Clark, G Moldenhauer, B Dörken, A Pezzutto, Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140. Journal of Immunology. ,vol. 138, pp. 98- 103 ,(1987)
T F Tedder, S F Schlossman, Phosphorylation of the B1 (CD20) molecule by normal and malignant human B lymphocytes. Journal of Biological Chemistry. ,vol. 263, pp. 10009- 10015 ,(1988) , 10.1016/S0021-9258(19)81618-6